BNTC Insider Trading Activity and SEC Form 4 Filings
BNTC insider trading summary
Over the past 12 months, insiders at Benitec Biopharma Inc. (BNTC) reported 32 open-market purchases worth $82.2M by 4 insiders and no sales on SEC Form 4. Net insider buying was $82.2M.
Latest BNTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 22, 2025 | Averill Madison Master Fund, Ltd. | Insider | Buy | $35K (2,892 @ $12.08) |
| Dec 22, 2025 | Aaron Cowen | Insider | Buy | $35K (2,892 @ $12.08) |
| Dec 22, 2025 | Suvretta Capital Management, LLC | Insider | Buy | $201K (16,650 @ $12.08) |
| Dec 22, 2025 | Averill Master Fund, Ltd. | Insider | Buy | $35K (2,892 @ $12.08) |
| Dec 22, 2025 | Suvretta Capital Management, LLC | Insider | Buy | $35K (2,892 @ $12.08) |
| Dec 22, 2025 | Aaron Cowen | Insider | Buy | $201K (16,650 @ $12.08) |
| Dec 22, 2025 | Averill Madison Master Fund, Ltd. | Insider | Buy | $201K (16,650 @ $12.08) |
| Dec 22, 2025 | Averill Master Fund, Ltd. | Insider | Buy | $201K (16,650 @ $12.08) |
| Dec 19, 2025 | Aaron Cowen | Insider | Buy | $28K (2,434 @ $11.48) |
| Dec 19, 2025 | Suvretta Capital Management, LLC | Insider | Buy | $160K (13,950 @ $11.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.